Simeon Kimmel MD, MA
Assistant Professor, General Internal Medicine
801 Massachusetts Ave | (617) 414-2846simeon.kimmel@bmc.org
sdkimmel@bu.edu

Sections
General Internal Medicine
Centers
Clinical Addiction Research and Education Unit
Biography
Simeon Kimmel is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine and an Attending Physician in the Sections of General Internal Medicine and Infectious Diseases at Boston Medical Center and Medical Director of Project TRUST, Boston Medical Center’s harm reduction focused drop-in center. He trained in Internal Medicine and Primary Care at Brigham and Women’s Hospital before completing a joint fellowship in Addiction Medicine and Infectious Diseases at Boston Medical Center. He also earned a Master's Degree in Medical Anthropology from the Harvard Graduate School of Arts and Sciences. His research focuses on improving retention in treatment with medications for opioid use disorder following serious injection related infections as well as the integration of addiction and harm reduction services with infectious disease care. He was awarded a Career Development Award from NIDA in 2021.
Education
MD, Harvard Medical School
MA, Harvard Graduate School of Arts and Sciences
Publications
Benheim TS, Kimmel SD, George M, Dow PM. Readmissions and Mortality After "Before Medically Advised" Hospital Discharges Among Medicare Beneficiaries with Opioid Use Disorder. J Gen Intern Med. 2025 Jan 28. PMID: 39875771.
Published on 12/17/2024Bovell-Ammon BJ, Onofrey S, Kimmel SD, Wurcel AG, Klevens M. Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study. Res Sq. 2024 Dec 17. PMID: 39764124.
Published on 11/8/2024Rosenmoss S, LaRochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, Yan S, Walley AY, Kimmel SD. Racial and Ethnic Disparities in Referral Rejection from Postacute Care Facilities among People with Opioid Use Disorder in Massachusetts. J Addict Med. 2024 Nov 08. PMID: 39514897.
Published on 10/8/2024Nishar S, Soske J, Vanjani R, Kimmel SD, Roma C, Dow PM. Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary. Int J Drug Policy. 2024 Nov; 133:104607. PMID: 39383611.
Published on 8/1/2024Christine PJ, Chahine RA, Kimmel SD, Mack N, Douglas C, Stopka TJ, Calver K, Fanucchi LC, Slavova S, Lofwall M, Feaster DJ, Lyons M, Ezell J, Larochelle MR. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. JAMA Netw Open. 2024 Aug 01; 7(8):e2425999. PMID: 39102264.
Published on 7/30/2024Parbs JR, Srinivasan S, Pustz J, Bayly R, Shrestha S, Lewis O, Kimmel S, Meehan T, Babakhanlou-Chase H, Stopka TJ. The optimization of harm reduction services in Massachusetts through the use of GIS: Location-allocation analyses, 2019-2021. Prev Med. 2024 Sep; 186:108088. PMID: 39084414.
Published on 7/12/2024Paradise RK, Bazzi AR, Clarke J, Desmarais J, Hoyos-Cespedes A, Nurani A, O'Malley SE, Taylor S, Walley AY, Dooley D, Kimmel SD. Multilevel Factors Impacting Substance Use Treatment Access, Engagement, and Racial Equity Among Opioid Overdose Survivors in Boston, MA. J Gen Intern Med. 2024 Oct; 39(13):2390-2399. PMID: 38997532.
Published on 7/1/2024Kimmel SD, Walley AY, White LF, Yan S, Grella C, Majeski A, Stein MD, Bettano A, Bernson D, Drainoni ML, Samet JH, Larochelle MR. Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts. JAMA Netw Open. 2024 Jul 01; 7(7):e2421740. PMID: 39046742.
Published on 4/24/2024Idrisov B, Van Draanen J, Lodi S, Lunze K, Kimmel SD, Quinn EK, Truong V, Blokhina E, Gnatienko N, Krupitsky E, Samet JH, Williams EC. Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS Behav. 2024 Jul; 28(7):2239-2246. PMID: 38658481.
Published on 4/24/2024Fletcher L, Burrowes S, Sabin LL, McCann N, Khan GK, Ruiz-Mercado G, Johnson S, Kimmel SD, Pierre C, Drainoni ML. Long-Acting Injectable ART in Practice: A Mixed Methods Implementation Study Assessing the Feasibility of Using LAI ART in High Risk Populations and At Alternative Low Barrier Care Sites. AIDS Patient Care STDS. 2024 May; 38(5):221-229. PMID: 38656905.
Media Mentions
Published on 8/3/2023
Published on 8/2/2023
Published on 7/5/2023
Long-Acting, Injected HIV Meds Can Help Tough-to-Treat Patients
Published on 7/5/2023
Long-Acting, Injected HIV Meds Can Help Tough-to-Treat Patients
Published on 6/22/2022
Published on 5/17/2022
BMC Pilots Training Program to Improve Post-Acute Care for Patients with Substance Use Disorder
Published on 5/10/2022
Published on 4/20/2022
COVID-19: Unionized Nursing Homes Showed Lower Resident Mortality Rates
Published on 3/11/2022
Published on 3/8/2022
Patients with opioid use disorder often rejected for skilled follow-up care, study finds
View full list of 21 media mentions.